Primary cilia promote resistance to EGFR tyrosine kinase inhibitor, osimertinib, in non-small cell lung cancer.
Saved in:
| Title: | Primary cilia promote resistance to EGFR tyrosine kinase inhibitor, osimertinib, in non-small cell lung cancer. |
|---|---|
| Authors: | Wang L; The Hormel Institute, University of Minnesota, Austin, MN, USA., Pandit A; The Hormel Institute, University of Minnesota, Austin, MN, USA., Alam SK; The Hormel Institute, University of Minnesota, Austin, MN, USA., Skauge R; The Hormel Institute, University of Minnesota, Austin, MN, USA., Gradilone SA; The Hormel Institute, University of Minnesota, Austin, MN, USA.; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA., Hoeppner LH; The Hormel Institute, University of Minnesota, Austin, MN, USA.; Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA. |
| Source: | BioRxiv : the preprint server for biology [bioRxiv] 2026 Mar 05. Date of Electronic Publication: 2026 Mar 05. |
| Publication Type: | Journal Article; Preprint |
| Journal Info: | Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2692-8205 |
|---|---|
| DOI: | 10.64898/2026.03.03.709408 |
